domperidone has been researched along with Cognition Disorders in 1 studies
Domperidone: A specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms.
domperidone : 1-[3-(Piperidin-1-yl)propyl]-1,3-dihydro-2H-benzimidazol-2-one in which the 4-position of the piperidine ring is substituted by a 5-chloro-1,3-dihydro-2H-benzimidazol-2-on-1-yl group. A dopamine antagonist, it is used as an antiemetic for the short-term treatment of nausea and vomiting, and to control gastrointestinal effects of dopaminergic drugs given in the management of parkinsonism. The free base is used in oral suspensions, while the maleate salt is used in tablet preparations.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The off-awake daily duration and the levodopa dosage were significantly reduced in the patients infused with apomorphine." | 2.71 | Continuous apomorphine infusion (CAI) and neuropsychiatric disorders in patients with advanced Parkinson's disease: a follow-up of two years. ( Antonini, A; Basile, G; Di Rosa, AE; Di Rosa, E; Epifanio, A; La Spina, P; Marconi, R; Martino, G; Morgante, L; Nicita-Mauro, V; Spina, E; Stocchi, F, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morgante, L | 1 |
| Basile, G | 1 |
| Epifanio, A | 1 |
| Spina, E | 1 |
| Antonini, A | 1 |
| Stocchi, F | 1 |
| Di Rosa, E | 1 |
| Martino, G | 1 |
| Marconi, R | 1 |
| La Spina, P | 1 |
| Nicita-Mauro, V | 1 |
| Di Rosa, AE | 1 |
1 trial available for domperidone and Cognition Disorders
| Article | Year |
|---|---|
Continuous apomorphine infusion (CAI) and neuropsychiatric disorders in patients with advanced Parkinson's disease: a follow-up of two years.
Topics: Antiemetics; Apomorphine; Brain; Cognition Disorders; Depression; Domperidone; Dopamine Agonists; Dr | 2004 |